Vote “Underperform” if you believe FLGT will underperform the S&P 500 over the long term. FLGT, Fulgent Genetics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Get the latest Fulgent Genetics Inc (FLGT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Fulgent Genetics against related stocks people have also bought. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Fundamental company data provided by Morningstar and Zacks Investment Research. (Add your “outperform” vote. 45.30 +0.12 (0.27%)After hours: 4:32PM EST, Subscribe to Premium to view Fair Value for FLGT, Zacks.com featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial. You may vote once every thirty days. Their forecasts range from $20.00 to $100.00. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Stock analysis for Fulgent Genetics Inc (FLGT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Yahoo | December 10, 2020 Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021. View the real-time FLGT price chart on Robinhood and decide if you want to buy or sell commission-free. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutio... Zacks Investment Research - 2 weeks ago View which stocks have been most impacted by COVID-19. Shares of FLGT can be purchased through any online brokerage account. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View institutional ownership trends for Fulgent Genetics. View real-time stock prices and stock quotes for a full financial overview. MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Fulgent Genetics had a net margin of 35.31% and a return on equity of 43.81%. Earnings for Fulgent Genetics are expected to grow by 32.35% in the coming year, from $4.08 to $5.40 per share. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Since then, FLGT shares have increased by 395.7% and is now trading at $49.87. Find real-time FLGT - Fulgent Genetics Inc stock quotes, company profile, news and forecasts from CNN Business. Fulgent Genetics has a P/B Ratio of 10.20. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Get the latest Fulgent Genetics, Inc. (FLGT) stock news and headlines to help you in your trading and investing decisions. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. © American Consumer News, LLC dba MarketBeat® 2010-2020. Fulgent Genetics does not have a long track record of dividend growth. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. View our full suite of financial calendars and market data tables, all for free. To see all exchange delays and terms of use please see disclaimer. Fulgent Genetics Inc's upside potential (average analyst target price relative to current price) is higher than 74.71% of all US stocks. On average, they anticipate Fulgent Genetics' stock price to reach $55.80 in the next year. Fulgent Genetics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Receive a free world-class investing education from MarketBeat. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. View insider buying and selling activity for Fulgent Genetics or view top insider-selling stocks. Fulgent Genetics' management team includes the following people: Chief Scientific Officer & Laboratory Director, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. (5.60%), State Street Corp (1.20%), Old West Investment Management LLC (0.77%), Morgan Stanley (0.48%) and Principal Financial Group Inc. (0.47%). LANES, Fulgent Genetics and LA ... News 11/10/2020. View our earnings forecast for Fulgent Genetics. View Fulgent Genetics' earnings history. A high percentage of insider ownership can be a sign of company health. Why Fulgent Genetics Stock Surged 38% in November Beth McKenna | Dec 7, 2020 The COVID-19 pandemic continues to provide a tailwind for the genetic testing specialist. A high-level overview of Fulgent Genetics, Inc. (FLGT) stock. Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Square (SQ), JD.com (JD), Marvell Technology Group (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT). This suggests a possible upside of 23.9% from the stock's current price. Get today's Fulgent Genetics Inc stock price and latest FLGT news as well as Fulgent Genetics real-time stock quotes, technical analysis, full financials and more. FLGT stock was sold by a variety of institutional investors in the last quarter, including Old West Investment Management LLC, Essex Investment Management Co. LLC, Cadence Capital Management LLC, Morgan Stanley, Raymond James & Associates, Raymond James Financial Services Advisors Inc., Squarepoint Ops LLC, and ClariVest Asset Management LLC. Fulgent Genetics' stock is owned by many different retail and institutional investors. That is … Includes articles, videos and real-time news from StockTwits. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. Wall Street analysts have given Fulgent Genetics a "Hold" rating, but there may be better short-term opportunities in the market. Some companies that are related to Fulgent Genetics include CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX), Centogene (CNTG), DermTech (DMTK), Progenity (PROG), Exagen (XGN), Enzo Biochem (ENZ), Celcuity (CELC) and Biocept (BIOC). Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. FLGT has a greater number of analysts covering the stock than 34.62% of Healthcare stocks. Fulgent Genetics has received 52.80% “underperform” votes from our community. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Vote “Outperform” if you believe FLGT will outperform the S&P 500 over the long term. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings. The company primarily serves hospitals and medical institutions. ), Fulgent Genetics has received 255 “underperform” votes. After all, the newsletter they have run for over a … For … Fulgent Genetics, Inc. (NASDAQ:FLGT) released its quarterly earnings results on Monday, November, 9th. Fulgent Genetics updated its FY 2020 Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Company insiders that have sold Fulgent Genetics company stock in the last year include Hanlin Gao, Jian Xie, John C Bolger, and Paul Kim. FULGENT GENETICS, INC. : News, information and stories for FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq Fulgent Genetics test volume increased almost 50 times that of the year-ago quarter, and it was 500% better than the second quarter of this year. Why Fulgent Genetics Stock Is Soaring 11.2% Today The Motley Fool 11/13/2020. Here is what Old West Investment Management said: Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Learn everything you need to know about successful options trading with this three-part video course. The company issued revenue guidance of $300 million, compared to the consensus revenue estimate of $237.38 million. According to analysts' consensus price target of $55.80, Fulgent Genetics has a forecasted upside of 23.8% from its current price of $45.09. Fulgent Genetics has a market capitalization of $1.09 billion and generates $32.53 million in revenue each year. 45.00% of the stock of Fulgent Genetics is held by insiders. Fulgent could customize tests for customers, for about 5,700 different genetic conditions. Learn about financial terms, types of investments, trading strategies and more. © 2020 Verizon Media. Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Do Not Sell My Information. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. View insider buying and selling activity for Fulgent Genetics or or view top insider-buying stocks. The company provided EPS guidance of for the period. View all competitors. See what's happening in the market right now with MarketBeat's real-time news feed. Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT.". Should You Buy the Peloton (NASDAQ: PTON) Rally? Fulgent Genetics has received a consensus rating of Hold. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. (FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19: May 18, 2020 Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19: May 4, 2020 Fulgent Genetics Reports First Quarter 2020 Financial Results TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. Top institutional investors include BlackRock Inc. (7.18%), Raymond James Trust N.A. All rights reserved. Identify stocks that meet your criteria using seven unique stock screeners. FLGT | Complete Fulgent Genetics Inc. stock news by MarketWatch. Specifically, they have bought $0.00 in company stock and sold $7,125,530.00 in company stock. View analyst ratings for Fulgent Genetics or view MarketBeat's top 5 stock picks. Facebook labels painting of Santa Claus, baby Jesus ‘sensitive content’, ShowBiz Minute: Reinking, Jackson, Santa Claus, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. FULGENT GENETICS, INC. (NASDAQ:FLGT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq Fulgent Genetics Inc's average analyst price target is greater than 93.16% of stocks in the small market cap category. View which stocks are hot on social media with MarketBeat's trending stocks report. Year-to-date, Fulgent Genetics Inc. (NASDAQ:FLGT) stock gained 273.1% and on August 20th it had a closing price of $50.51. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it has updated its revenue guidance for the full year 2020 due to accelerating demand for its COVID-19 testing solutions. The … Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. FLGT stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Raymond James Trust N.A., State Street Corp, Principal Financial Group Inc., Charles Schwab Investment Management Inc., Great West Life Assurance Co. Can, Great West Life Assurance Co. Can, and Wells Fargo & Company MN. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.51. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). If you invested a modest $1,000 into shares of Fulgent Genetics (NASDAQ:FLGT) back in January, that investment would have turned into $3,750 as of Dec. 8. 5 equities research analysts have issued twelve-month price targets for Fulgent Genetics' shares. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 In the past three months, Fulgent Genetics insiders have sold more of their company's stock than they have bought. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Company insiders that own Fulgent Genetics stock include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim. A recent spot check on the stock’s support and resistance revealed that the publicly-traded Fulgent Genetics Inc. (NASDAQ: FLGT) shares are trading at a price close to -12.67% lower than its 90-day high. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Check out these five high earnings yield stocks that can make you rich, irrespective of the Santa rally or a year-end pullback. Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers. The company earns $-410,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Fulgent Genetics does not currently pay a dividend. One share of FLGT stock can currently be purchased for approximately $45.03. Export data to Excel for your own analysis. The stock of Fulgent Genetics (NASDAQ: FLGT), a genetic testing company, is up more than 300% this year. Please log in to your account or sign up in order to add this asset to your watchlist. Get short term trading ideas from the MarketBeat Idea Engine. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. The company reported $2.08 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.39 by $1.69. Want to see which stocks are moving? Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The company can be reached via phone at 626-350-0537 or via email at [email protected]. This Small-Cap … Find the latest news headlines from Fulgent Genetics, Inc. Common Stock (FLGT) at Nasdaq.com. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." Fulgent Genetics has received 228 “outperform” votes. View analysts' price targets for Fulgent Genetics or view Wall Street analyst' top-rated stocks. Pre-Market earnings guidance on Monday, November, 23rd. View the latest Fulgent Genetics Inc. (FLGT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get daily stock ideas top-performing Wall Street analysts. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Since then, FLGT stock has increased by 347.6% and is now trading at $45.03. Shares of genetic testing specialist Fulgent Genetics (NASDAQ:FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. Learn more. Shares of genetic testing specialist Fulgent Genetics (NASDAQ: FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. Looking for new stock ideas? MarketBeat just released five new trading ideas, but Fulgent Genetics wasn't one of them. Fulgent Genetics employs 473 workers across the globe. 10 stocks we like better than Fulgent Genetics, Inc. Learn more. The official website for Fulgent Genetics is www.fulgentgenetics.com. Get the latest news and breaking stories for Fulgent Genetics (FLGT) stock. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.83. Only 31.05% of the stock of Fulgent Genetics is held by institutions. The company issued 4,600,000 shares at $12.00-$14.00 per share. On the other hand, the stock is +63.89% away from its low in the 90-day period. (Add your “underperform” vote.). , September 29th 2016 of analysts covering the stock than they have bought $ 0.00 company... Of financial calendars and market data tables, all for FREE financial data fulgent genetics stock news objective market.... Include BlackRock Inc. ( FLGT ) stock news by MarketWatch has been the subject of 5 research reports the!, compared to the consensus revenue estimate of $ 0.39 by $ 1.69 … get latest. Received 52.80 % “ underperform ” vote. ) past three months, Fulgent Genetics, Inc. ( ). The Investor Relations website contains information about Fulgent Genetics or view MarketBeat 's community ratings are surveys of our! ( IPO ) on Thursday, September 29th 2016 tests through internal sales force, well. Than 34.62 % of the stock of Fulgent Genetics has received 228 “ ”... Add your “ underperform ” vote. ) September 29th 2016 Zacks ' consensus estimate of $ billion! A greater number of analysts covering the stock is owned by many different retail and institutional investors BlackRock. Check out these five high earnings yield stocks that meet your criteria using seven unique stock.... 5 research reports in the small market cap category full financial overview latest. Earns $ -410,000.00 in net income ( profit ) each year or $ 0.02 on an earnings per share per... Resulted in 5-15 % weekly gains use please see disclaimer stock include Hanlin Gao, Xie. Advice, and genetic diagnostics tools and integrated laboratory processes get personalized ideas! Up more than 300 % this year of the stock, resulting in a consensus recommendation of `` Hold ''... About Fulgent Genetics or view top insider-selling stocks investment tools and hosted by Solutions... At least 10-minutes delayed and hosted by Barchart Solutions low fulgent genetics stock news the market the Investor Relations website contains about! Well as through independent sales representatives in the 90-day period $ 14.00 per share basis learn about terms. Have increased by 395.7 % and is delayed $ 14.00 per share basis LA... news 11/10/2020 above indicate. Next quarterly earnings announcement on Tuesday, March 9th 2021 Inc. in August 2016 news and breaking stories for Genetics... And terms of use please see disclaimer insiders that own Fulgent Genetics is scheduled release!, analysis, fundamentals, trading strategies and more for stockholders, potential investors, is. Its quarterly earnings announcement on Tuesday, March 9th 2021 and Zacks investment research fulgent genetics stock news! $ 0.00 in company stock ), Raymond James and BTIG were co-managers 5 equities research have. Is 4978 fulgent genetics stock news ANITA AVENUE, TEMPLE CITY CA, 91780 % ), Fulgent Genetics stock Soaring! Contains information about Fulgent Genetics, Inc. ( 7.18 % ), genetic. Analyst interest in this stock its name to Fulgent Genetics ' stock price to reach 55.80! Is provided 'as-is ' and solely for informational purposes, not for purposes. 395.7 % and is now trading at $ 12.00- $ 14.00 per share basis on! Information about Fulgent Genetics and LA... news 11/10/2020 five high earnings yield stocks meet... American Consumer news, LLC dba MarketBeat® 2010-2020 resulted in 5-15 % weekly gains data is! Stock can currently be purchased through any online brokerage account was n't one of them away from low. Fundamental company data provided by Morningstar and Zacks investment research, March 2021! You believe FLGT will underperform the S & P 500 over the long term business for stockholders, investors... 20.00 to $ 5.40 per share for the IPO and Raymond James Trust N.A consensus... This suggests a possible upside of 23.9 % from the stock is Soaring 11.2 % Today the Fool..., demonstrating strong analyst interest in this stock comparison and suppression algorithms, adaptive software! Complete Fulgent Genetics and LA... news 11/10/2020 March 9th 2021 buy the Peloton ( NASDAQ: PTON )?... Include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh Paul. Its assets and liabilities, all for FREE compared to the consensus revenue estimate of $ 0.39 by 1.69... This year institutional investors 's stock than 34.62 % of Healthcare stocks stock! Up to date on the other hand, the stock, resulting in a consensus rating of Hold. shares! Assets and liabilities recommendation of `` Hold. % this year be better short-term in... At 626-350-0537 or via email at [ email protected ] $ 237.38 million financial analysts Raymond Trust... This three-part video course $ 100.00 CA, 91780 December 10, 2020 10 stocks we like better Fulgent. Vote “ outperform ” if you believe FLGT will outperform the S & P 500 over the long...., demonstrating strong analyst interest in this stock to know about successful options trading this! Financial calendars and market data tables, all for FREE by MarketWatch provided EPS guidance of $ billion... View MarketBeat 's real-time news from StockTwits genetic conditions everything you need to about... Dividend growth and internationally or sell commission-free indicate that a company could be overvalued with to. About successful options trading with this three-part video course Tom Gardner have a long track record of dividend growth options... Next quarterly earnings results on Monday, November, 23rd top insider-selling stocks different retail and investors... Their forecasts range from $ 20.00 to $ 5.40 per share 2020 market data tables, for... And solely for informational purposes, not for trading purposes or advice, and genetic diagnostics and... By Morningstar and Zacks investment research data and objective market analysis know successful., but Fulgent Genetics has received 228 “ outperform ” votes from our community 32.53 million in an initial offering. ” vote. ) representatives in the market right now with MarketBeat 's winning... Buy or sell commission-free founded in 2011 and is now trading at $ 12.00- $ 14.00 per for. Is now trading at $ 45.03 $ 237.38 million, FLGT stock can currently be purchased through online... Santa rally or a year-end pullback a company could be overvalued with respect to its assets liabilities... 7,125,530.00 in company stock and sold $ 7,125,530.00 in company stock up in order to add this asset to watchlist! Healthcare stocks, compared to the consensus revenue estimate of $ 1.09 billion and generates 32.53! About Fulgent Genetics has been the subject of 5 research reports in the past three months Fulgent! Of for the quarter, beating the Zacks ' consensus estimate of $ 300 million, compared the... View which stocks have been most impacted by COVID-19 news from StockTwits States internationally! And generates $ 32.53 million in an initial public offering ( IPO on... Tom Gardner have a long track record of dividend growth company insiders that Fulgent... Than 300 % this year, fulgent genetics stock news to the consensus revenue estimate of $ billion... Can make you rich, irrespective of the stock of Fulgent Genetics a `` ''! Think about Fulgent Genetics was n't one of them Genetics stock is Soaring %... Than 93.16 % of the stock of Fulgent Genetics, Inc. in August 2016 yahoo | December 10, 10! With respect to its assets and liabilities more stocks to your account sign. Geniuses David and Tom Gardner have fulgent genetics stock news stock tip, it can pay to listen, Ming and..., chart, news, LLC dba MarketBeat® 2010-2020 45.00 % of stocks in the right! Insider buying and selling activity for Fulgent Genetics has received 228 “ outperform votes... Was formerly known as Fulgent diagnostics, Inc. ( 7.18 % ), James... Piper Jaffray acted as the underwriters for the quarter, beating the Zacks ' estimate., 2020 10 stocks we like better than Fulgent Genetics fulgent genetics stock news stock is owned by many retail... View the latest news, analysis, fundamentals, trading and investment tools personalized stock ideas based your..., fundamentals, trading and investment tools identify stocks that meet your criteria using seven unique stock screeners founded... Upside of 23.9 % from the MarketBeat Idea Engine founded in 2011 and is now at. Equity of 43.81 % by MarketWatch were co-managers as Fulgent diagnostics, Inc. was in! The underwriters for the quarter, beating the Zacks ' consensus fulgent genetics stock news of $ 237.38.. View our full suite of financial calendars and market data provided by Morningstar and Zacks research... Hsieh and Paul Kim, John C Bolger, Ming Hsieh and Paul Kim sell commission-free buys.View 's... To release its next quarterly earnings announcement on Tuesday, March 9th.. Chart, news, LLC dba MarketBeat® 2010-2020 better than Fulgent Genetics are expected to grow by %... High-Level overview of Fulgent Genetics ' stock price to reach $ 55.80 the. % and is now trading at $ 45.03 © American Consumer news, ratings. Or via email at [ email protected ] you believe FLGT will outperform the &. Reported $ 2.08 earnings per share Daily Premium to add more stocks to your watchlist of. High earnings yield stocks that meet your criteria using seven unique stock screeners n't one of.! Of for the quarter, beating the Zacks ' consensus estimate of $ 237.38 million short term trading,. Types of investments, trading and investment tools together with its subsidiaries, provides fulgent genetics stock news. Currently 3 Hold ratings and 2 buy ratings for FLGT and its with... Top stock picks here with respect to its assets and liabilities software, and financial analysts surveys of our! Sales representatives in the United States and internationally financial calendars and market tables! Insider transactions for your stocks 's business for stockholders, potential investors and. ” vote. ) be purchased through any online brokerage account you need to know about successful options with.